24 Changing to BASAGLAR from Other Insulin Therapies If changing patients from another insulin glargine product, 100 units/mL, to BASAGLAR, the dose of BASAGLAR should be the same as the other insulin glargine product, 100 units/mL, and the time of day for administration should be determined by the physicianA Opened (inuse) Tresiba ® should be refrigerated (36°F to 46°F 2°C to 8°C) or kept at room temperature (below 86°F 30°C), away from direct heat and light 1 b Opened (inuse) Lantus ® SoloSTAR ® devices must be discarded 4 weeks after being opened Once in use, the device must be kept at room temperature and should not be refrigerated 2 c The inuse insulin glargine U100How do I use this basaglar kwikpen u100 discount card?
How to read a 100 unit insulin syringe
How to read a 100 unit insulin syringe-About Basaglar KwikPen U100 Insulin Overview Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetesBasaglar 100U/ml Kwikpen 5x3ml Unfortunately our full catalog may not be displayed in your state If you contact our Customer Support by one of the methods below, we will be able to assist you in locating the product you are looking for Customer Support Phone
Hypoglycemia is the most common adverse reaction associated with insulins, including BASAGLAR Severe hypoglycemia can cause seizures, may be lifethreatening, or cause death Accidental mixups between another insulin glargine product (100 units/mL) and other insulins, particularly rapidacting insulins, have been reportedInjection 100 units/mL (U100) in 3 mL prefilled BASAGLAR KwikPen delivery device (3) CONTRAINDICATIONS • During episodes of hypoglycemia(4) • Hypersensitivity to BASAGLAR or one of its excipients(4) WARNINGS AND PRECAUTIONS • Never share a BASAGLAR KwikPen between patients, even if theWebMD provides information about interactions between Basaglar KwikPen U100 Insulin subcutaneous and antipsychoticssibutramine
INDIANAPOLIS and RIDGEFIELD, CT – Dec 15, 16 – Eli Lilly and Company (NYSE LLY) and Boehringer Ingelheim Pharmaceuticals, Inc announced today that BASAGLAR ® (insulin glargine injection 100 units/mL) is available by prescription in the US BASAGLAR is a followon insulin to Lantus ®It is a longacting insulin with an amino acid sequence identical to Lantus, another U100 insulinBASAGLAR KWIKPEN U100 Savings, Coupons and Information INSULIN GLARGINE (IN su lin GLAR geen) is a humanmade form of insulin This drug lowers the amount of sugar in your bloodInsulin cartridges Basaglar 5×30 ml;
Drug Name Basaglar Kwikpen U 100 Toujeo Solostar;Sanofi insulins included in this program are ADMELOG (insulin lispro injection) 100 Units/mL, TOUJEO ® (insulin glargine injection) 300 Units/mL, LANTUS ® (insulin glargine injection) 100 Units/mL and APIDRA ® (insulin glulisine injection) 100 units/mL The Insulins Valyou Savings Program applies to the cost of medication There are other relevant costs associated with overallBasaglar KwikPen U100 Insulin 100 unit/mL (3 mL) subcutaneous Loading View more photos The photos shown are samples only Not all photos of the drug may be displayed Your medication may look different If you have questions, ask your pharmacist close popup Medication name
0 件のコメント:
コメントを投稿